Investigació Aplicada en Malalties Respiratòries


  • Monday, 06/21/2021

    Alba Soler joins the IAMR group as a research technician in the study "Human recombinant interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients" - the PREV-HAP study.

     Alba Soler holds a degree in Biology from the University of Barcelona since February 2021, mainly focused on molecular, cellular and systems biology. She enrolled the research group in July 2020 to perform her End of Grade Thesis entitled "Bacterial lung chassis for treating biofim-associated human respiratory infections", which obtained the highest scoring "Matrícula d'Honor" and was directed by Dr. Antoni Torres and Dr. Laia Fernandez-Barat. Now is under revision. Alba's End of Grade project is integrated in another project with competitive funding from La Caixa Health Research grants 2018 lead by Prof. Luis Serrano from Center from Genomic Regulation and Prof. Torres from IDIBAPS.

    Additionally, during her research internship she has been actively participating in several projects of the group, entering data in the CIBERESUCICOVID study, learning how the microbiological analysis of respiratory samples works in various porcine animal model experiments and performing the microbiological and microbiome analysis of human endotracheal tubes.

    From now on, she will also be in charge of the processing of respiratory fluid and blood samples (peripheral blood mononuclear cells, whole blood plasma) from patients progressively included in the PREV-HAP study.

  • Friday, 06/04/2021

    Award for the best Abstract

      Award for the best Abstract

    SOCAP in the celebration of its XXXVIII “Diada Pneumológica” has awarded the Award for the best Abstract to our researchers for their participation in the CIBERESUCICOVID project in the research of Covid-19.


  • Friday, 05/07/2021

    One year has passed since the start of 2 research projects on COVID-19

    One year has passed since the start of 2 research projects on COVID-19 funded by the Government of Catalonia and the Carlos III Institute of Health of the Ministry of Science and Innovation. 


More news

Subscribe to news